While the Africentric Personal Development Shop may not be well known by the Greater Columbus community, CEO Jerry Saunders Sr. says it has the most important factor down — street credibility. Since ...
Pune, INDIA., April 05, 2023 (GLOBE NEWSWIRE) -- According to our new research study on “Artificial Pancreas Device System Market Forecast to 2028 – by Type and Geography,” the market is expected to ...
Pharming’s Joenja receives European marketing authorization for the treatment of activated PI3K delta syndrome: Leiden, the Netherlands Tuesday, May 26, 2026, 13:00 Hrs [IST] Ph ...
Joenja® (leniolisib) is first approved treatment in the European Union for activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency, in adult and pediatric ...
Pharming's Joenja has become the first disease-modifying drug that can be used by the NHS to treat activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), an ultra-rare immunodeficiency ...
A Prescription Drug User Fee Act target date of January 31, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental New Drug ...
NEW YORK, Nov. 13, 2023 (GLOBE NEWSWIRE) -- Today, American Prison Data Systems (APDS), announces a major renaming effort to become Orijin. Like APDS, Orijin’s mission is to prepare every ...
Please provide your email address to receive an email when new articles are posted on . There is no current treatment for children with APDS aged 4 to 11 years. Diagnostic delays have a mean of 7 ...
NEW YORK--(BUSINESS WIRE)--APDS, a public-benefit corporation whose advanced career readiness platform helps incarcerated individuals attain a living wage after release, today announced that it has ...
Pharming’s investigational treatment for activated phosphoinositide 3-kinase delta syndrome (APDS) has been granted orphan drug designation from the European Commission. The designation awarded to ...
American Prison Data Systems, a New York City-based provider of educational devices and instructional technology to correctional facilities, has raised $5 million in Series B funding led by New ...